ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

0QSS Phaxiam Therapeutics

71.025
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Phaxiam Therapeutics LSE:0QSS London Ordinary Share FR001400K4B1 PHAXIAM THERAPEUTICS ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 71.025 6.925 7.28 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1.33M -23.49M - N/A 0

Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024

05/03/2024 5:00pm

UK Regulatory


Phaxiam Therapeutics (LSE:0QSS)
Historical Stock Chart


From Mar 2024 to May 2024

Click Here for more Phaxiam Therapeutics Charts.
Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024


Monthly information related to total number of voting rights and shares composing the share capital - February 29, 2024

Article 223-16 of general regulation of French Autorité des Marchés Financiers


Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM) &
Nasdaq Global Select Market in the United-States (Symbol: PHXM)
Website : www.phaxiam.com

DateTotal of shares composing the share capitalTotal of brut (1) voting rights

Total of net (2) voting rights

December 31, 20236 075 1056 226 9826 226 733
January 31, 20246 075 1056 227 0026 226 753
February 29, 20246 075 1056 226 9516 226 702

(1)   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2)   Without treasury shares.

Attachment

  • CP_Déclaration Droits de Vote 29 02 2024_vENG

1 Year Phaxiam Therapeutics Chart

1 Year Phaxiam Therapeutics Chart

1 Month Phaxiam Therapeutics Chart

1 Month Phaxiam Therapeutics Chart

Your Recent History

Delayed Upgrade Clock